Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Treatment received by 33 subjects achieving concomitant CR, biochemical remission (FC level <94 μg/g and CRP < 5 mg/L), MH, and TH.
| No. of patients treated (entire population) | No. of patients achieving DR | |
|---|---|---|
| Adalimumab | 75 | 21 (28%) |
| Infliximab | 10 | 3 (30%) |
| Vedolizumab | 18 | 5 (27.7%) |
| Ustekinumab | 15 | 4 (26.7%) |
CR, clinical remission; CRP, C-reactive protein; DE, Deep remission; FC, fecal calprotectin; MH, mucosal healing; TH, transmural healing.
